Patents/Assignees

Momenta Pharmaceuticals, Inc.

19 patents in portfolio

US12595454utility2026
Methods of Continuous Cell Culture
0 cites
US12559542utility2026
Glycoproteins with Anti-inflammatory Properties
0 cites
US12528867utility2026
FCRN Antibody Compositions
0 cites
US12460006utility2025
Antibodies Against Integrin Alpha 11 Beta 1
0 cites
US12391759utility2025
Methods Related to Engineered Fc Constructs
0 cites
US12360119utility2025
Methods Related to Biologics
0 cites
US12304950utility2025
Methods of Producing Ustekinumab
0 cites
US12297256utility2025
Methods for the Treatment of Neurodegeneration
0 cites
US12297291utility2025
Compositions and Methods Related to Engineered Fc Constructs
0 cites
US12163951utility2024
Methods for Predicting Response to Treatment
0 cites
US12139735utility2024
Cell Culture Process
0 cites
US12071482utility2024
Compositions and Methods Related to Engineered Fc Constructs
0 cites
US11827682utility2023
Engineered Fc Constructs
0 cites
US11773168utility2023
Fcrn Antibodies and Methods of Use Thereof
0 cites
US11732047utility2023
Fcrn Antibodies and Methods of Use Thereof
0 cites
US11719704utility2023
Methods Related to Biologics
0 cites
US11661456utility2023
Sialylated Glycoproteins
0 cites
US11639923utility2023
Methods for Predicting Response to Treatment
0 cites
US11623964utility2023
Compositions and Methods Related to Engineered Fc Constructs
0 cites